There is evidence that a variety of anticancer drugs exert their cytot
oxic activity by a free-radical-mediated mechanism. These drugs includ
e anthracyclines such as adriamycin, daunorubicin, 4-epi-adriblastin a
s well as bleomycin, procarbazine, vincristin, cyclophosphamide, etopo
side and mitomycin C. The aim of this study was to investigate whether
cancer patients who underwent polychemotherapy (n = 44) show more sig
ns of oxidative stress in plasma than a group of healthy controls (n =
52). As an index of free radical generation, plasma concentrations of
thiobarbituric-acid-reactive substances (TBARS), well-accepted as mar
kers for oxidative stress, were determined by fluorometric detection a
fter separation by high-performance liquid chromatography. In 12 cases
, the TBARS were measured both before and after a chemotherapy course.
After chemotherapy, 10 of 12 patients showed a marked increase in pla
sma TBARS concentration compared to values measured before therapy [9.
02+/-1.84 nmol/ml (n = 12) vs. 11.58+/-2.49 nmol/ml (n = 12); p = 0.00
2, t-test for paired observations]. Tumor patients in general had sign
ificantly larger amounts of TBARS in plasma in comparison with a contr
ol group [mean 11.88+/-3.51 nmol/ml (n = 44) vs. 7.51+/-2.14 nmol/ml (
n = 52); p < 0.001, t test]. Our results are evidence that repetitive
polychemotherapy with radical-generating compounds may exceed the anti
oxidative capacities of cancer patients and may lead to oxidative stre
ss.